TCM Stock

TCM EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of TCM (524156.BO) as of Jul 13, 2026 is -14.49. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -12.93 — a change of 12.04% (lower).

EV/EBIT

-14.49

YoY

12.04%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of TCM is 2026 -14.49 . EV/EBIT (Enterprise Value to EBIT) of TCM was 2025 -12.93 . It decreases by 12.04% lower compared to the previous year.

The TCM EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2018
0.00 base
Jan 1, 2019
0.00 base
Jan 1, 2020
-10.61 base
Jan 1, 2021
-14.76 base
Jan 1, 2022
-5.70 base
Jan 1, 2023
-7.80 base
Jan 1, 2024
-13.02 base
Jan 1, 2025
-21.17 base
YEARPRICE-TO-EBIT
2025 -21.17
2024 -13.02
2023 -7.80
2022 -5.70
2021 -14.76
2020 -10.61
2019 -
2018 -
Access this data via the Eulerpool API
Get Free API Key

TCM Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides TCM's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates TCM's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots TCM's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if TCM grows earnings faster than its peers.

TCM Stock analysis

What does TCM do? TCM is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TCM stock

EV/EBIT (Enterprise Value to EBIT) of TCM is -14.49 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — TCM

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — TCM